On 2026-05-14, Inhibrx Biosciences, Inc. (INBX) announced earnings per share of $-2.15 for the fiscal quarter ending 2026-03-31, beating the average analyst estimate of $-2.37.
The next expected annoucement date for quarterly earnings is 2026-08-12, with an average estimated earnings per share of $-2.50 for the fiscal quarter ending 2026-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-05-14 | 2026-03-31 | $-2.37 | $-2.15 |
| 2026-03-19 | 2025-12-31 | -- | $-2.11 |
| 2025-11-14 | 2025-09-30 | -- | $-2.28 |
| 2025-08-13 | 2025-06-30 | $-2.92 | $-1.85 |
| 2025-05-14 | 2025-03-31 | $-2.55 | $-2.80 |
| 2025-03-17 | 2024-12-31 | $-2.88 | $-3.09 |
| 2024-11-14 | 2024-09-30 | $-3.06 | $-2.84 |
| 2024-08-13 | 2024-06-30 | -- | $125.48 |